Avesthagen

From Wikipedia, the free encyclopedia
Avesthagen Limited
Type Public
Industry Biotechnology
Founded Bangalore, India, 1998
Founder(s) Dr Villoo Morawala-Patell
Headquarters Bangalore, India

Avesthagen Limited is a leading life science company pioneering the convergence between Food, Pharma and Population Genetics leading to Predictive Preventive Personalized Healthcare™.

The business model of Avesthagen is to combine IP & product development through in-house research and collaborations. Avesthagen has built and continues to build an integrated, systems biology approach of capabilities, products, infrastructure and technology that allows for and facilitates 'cross talk' between numerous disciplines, leading to unique and innovative solutions. We employ 450 people worldwide and are headquartered in Bangalore, India.[1] [2] It was founded in 1998 by Dr. Villoo Morawala-Patell, who is the current Chairperson and Managing Director of the Company.


Avestagenome Project

The A V E S T A G E N O M E Project™ is a systems-biology-based study of the Parsis, a genetically homogeneous community, which aims to determine the genetic basis of longevity and age-related disorders. It also aims to discover population-validated drug targets and molecular markers for diagnostics.[3]


References

  1. "Avesthagen to raise $60 mn in complex deal from Cayman-based fund". Business Standard. 12 May 2012. Retrieved 16 July 2012. 
  2. P.T. Jyothi Datta. "Decoding the longevity DNA of Parsis". The Hindu Business Line. Retrieved 2008-02-23. 
  3. "The A V E S T A G E N O M E project™ - a discovery model for disease genomics and beyond". 11 October 2010. 

Other:

External links

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.